Liver tissue examination

Journal of Hepatology

Volumn 39, Issue SUPPL. 1, 2003, Pages

  Desmet, Valeer J ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIGEN; HEPATITIS B(E) ANTIGEN;

ACUTE HEPATITIS; CHRONIC HEPATITIS; CLINICAL FEATURE; COMORBIDITY; CONFERENCE PAPER; DELTA AGENT HEPATITIS; ELECTRON MICROSCOPY; HEPATITIS B; HEPATITIS DELTA VIRUS; HISTOPATHOLOGY; HUMAN; IMMUNOELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIVER BIOPSY; LIVER TUMOR; NONHUMAN; PRECANCER; PRIORITY JOURNAL; RECURRENT INFECTION;

EID: 0141892191     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0168-8278(03)00138-7     Document Type: Conference Paper

References (118)

1. Desmet V, Fevery J. Liver biopsy. In: Hayes PC, editor. Baillieres clinical gastroenterology. International practice and research, 9 (nr. 4). London: Baillière Tindall; 1995. p. 811-28.
2. Ferrell LD, Theise ND, Scheuer PJ. Acute and chronic viral hepatitis. In: MacSween RNM, Burt AD, Portmann BC, Ishak KG, Scheuer PJ, Anthony PP, editors. Pathology of the liver, 4th ed. London: Churchill Livingstone; 2002. p. 313-62.
3. Scheuer PJ, Lefkowitch JH, editors. Liver biopsy interpretation, 6th ed. London: WB Saunders; 2000.
4. Kobayashi K, Hashimoto E, Ludwig J, Hisamitsu T, Obata H. Liver biopsy features of acute hepatitis C compared with hepatitis A, B and non-A, non-B, non-C. Liver 1993;13:69-73.
5. Bianchi L, De Groote J, Desmet VJ, Gedigk P, Korb G, Popper H, et al. Acute and chronic hepatitis revisited. Lancet 1977;II:914-9.
6. Boyer JL, Klatskin G. Pattern of necrosis in acute viral hepatitis. Prognostic value of bridging (subacute hepatic necrosis). N Engl J Med 1970;283:1063-71.
7. Scheuer PJ, Maggi G. Hepatic fibrosis and collapse: histological distinction by orcein staining. Histopathology 1980;4:487-90.
8. Bianchi L, De Groote J, Desmet V, Gedigk P, Korb G, Popper H, et al. Morphological criteria in viral hepatitis. Lancet 1971;I:333-7.
9. Desmet VJ. Acute viral hepatitis: hepatitis B. In: Gitnick G, editor. Modern concepts of acute and chronic hepatitis. New York: Plenum Publishing Corporation; 1989. p. 87-111.
10. Houthoff HJ, Niermeijer P, Gips CH, Arends A, Hofstee N. Hepatic morphologic findings and viral antigens in acute hepatitis B. A longitudinal study. Virchows Arch (A) 1980;389:153-66.
11. Ishak KG. Pathologic features of chronic hepatitis: a review and update. Am J Clin Pathol 2000;113:40-55.
12. Baptista A, Bianchi L, De Groote J, Desmet VJ, Ishak KG, Korb G, et al. The diagnostic significance of periportal hepatic necrosis and inflammation. Histopathology 1988;12:569-79.
13. Lau JY, Xie X, Lai MM, Wu PC. Apoptosis and viral hepatitis. Semin Liver Dis 1998;18:169-76.
14. Villari D, Raimondo G, Brancatelli S, Longo G, Rodino G, Smedile V. Histological features in liver biopsy specimens of patients with acute reactivation of chronic type B hepatitis. Histopathology 1991;18:73-7.
15. Cooksley WGE, Bradbear RA, Robinson W, Harrison M, Halliday JW, Powell LW. et al. The prognosis of chronic active hepatitis without cirrhosis in relation to bridging necrosis. Hepatology 1986;6:345-8.
16. Chen T, Liaw YF. The prognostic significance of bridging hepatic necrosis in chronic type B hepatitis: a histopathologic study. Liver 1988;8:10-16.
17. Cassiman D, Libbrecht L, Desmet V, Aertsen P, Denef C, Roskams T. Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers. J Hepatol 2002;36:200-9.
18. Libbrecht L, Desmet V, Van Damme B, Roskams T. Deep intralobular extension of human hepatic 'progenitor cells' correlates with parenchymal inflammation in chronic viral hepatitis: can 'progenitor cells' migrate? J Pathol 2000;192:373-8.
19. Desmet V. Liver lesions in hepatitis B viral infection. Yale J Biol Meal 1988;61:61-83.
20. Hadziyannis S, Gerber MA, Vissoulis C, Popper H. Cytoplasmic hepatitis B antigen in 'ground-glass' hepatocytes of carriers. Arch Pathol 1973;96:327-30.
21. Yamada G, Nakane PK, Hepatitis B. core and surface antigens in liver tissue. Light and electron microscopic localization by the peroxidase-labelled antibody method. Lab Invest 1977;26:649-59.
22. Shikata T, Uzawa T, Yoshiwara N, Akatsuka T, Yamazaki S. Staining methods of Australia antigen in paraffin section - detection of cytoplasmic inclusion bodies. Jpn J Exp Meal 1974;44:25-36.
23. Tanaka K, Mori W, Suwa K. Victoria blue-nuclear fast red stain for HBs antigen detection in paraffin sections. Acta Pathol Jpn 1981;31:93-8.
24. Callea F, De Vos R, Togni R, Tardanico R, Vanstapel MJ, Desmet VJ. Fibrinogen inclusions in liver cells: a new type of ground-glass hepatocyte. Immune light and electron microscopic characterization. Histopathology 1986;10:65-73.
25. Alonso-Marti C, Moreno A, Barat A, Solera JC, Oliva H. Co-existence of hepatocyte ground-glass inclusions from several causes. Histopathology 1990;16:304-7.
26. Czaja AJ, Carpenter HA. Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis. Gastroenterology 1993;105:1824-32.
27. Gerber MA, Thung SN. The diagnostic value of immunohistochemical demonstration of hepatitis viral antigens in liver. Hum Pathol 1987;18:771-4.
28. Merz H, Malisius R, Mannweiler S, Zhou R, Hartmann W, Orscheschek K, et al. ImmunoMax: a maximized immunohistochemical method for retrieval and enhancement of hidden antigens. Lab Invest 1995;73:149-56.
29. Sabattini E, Bisgaard K, Ascani S, Poggi S, Piccioli M, Cessarelli C, et al. The EnVision™+ system: a new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, ChemMate™, SCA, LABL and SABC techniques. J Clin Pathol 1998;51:506-11.
30. Bianchi L, Gudat F. Immunopathology of hepatitis B. In: Popper H, Schaffner F, editors. Progress in liver diseases, VI. New York: Grune and Stratton; 1979. p. 371-92.
31. Edgington TS, Chisari FV. Immunological aspects of hepatitis B virus infection. Am J Med Sci 1975;270:213-27.
32. Uchida T, Shimojima S, Gotoh K, Shikata T, Mima S. Pathology of livers infected with 'silent' hepatitis B virus mutant. Liver 1994;14:251-6.
33. Chu CM, Karayiannis P, Fowler MJF, Monjardino J, Liaw YF, Thomas HC. Natural history of chronic hepatitis B virus infection in Taiwan. Studies of hepatitis B virus DNA in serum. Hepatology 1985;5:431-4.
34. Chen DS. Natural history of chronic hepatitis B virus infection: new light on an old story. J Gastroenterol Hepatol 1993;8:470-5.
35. Lok ASF, McMahon BJ. Chronic hepatitis B. Hepatology 2001;34:1225-41.
36. Naoumov NV, Portmann BC. Tedder RS, Ferns B, Eddleston ALWF, Williams R. Detection of hepatitis B virus antigens in liver tissue. A relation to viral replication and histology in chronic hepatitis B infection. Gastroenterology 1990;99:1248-53.
37. Lindh M, Savage K, Rees J, Garwood L, Horal P, Norkrans G, et al. HBeAg immunostaining of liver tissue in various stages of chronic hepatitis B. Liver 1999;19:294-8.
38. Chu CM, Liaw YF. Membrane staining for hepatitis B surface antigen in hepatocytes: a sensitive and specific marker of active viral replicfition in hepatitis B. J Clin Pathol 1995;48:470-3.
39. Loriot MA, Marcellin P, Bismuth E, Martinot-Peignoux M, Boyer N, Degott C, et al. Demonstration of hepatitis B virus DNA by polymerase chain reaction in the serum and the liver after spontaneous or therapeutically induced HBeAg to anti-HBe or HBsAg to anti-HBs seroconversion in patients with chronic hepatitis B. Hepatology 1992;15:32-6.
40. Liaw YF, Yang SS, Chen TJ, Chu CM. Acute exacerbation in hepatitis B e antigen - positive chronic type B hepatitis - a clinicopathological study. J Hepatol 1985;1:227-33.
41. Chu CM, Liaw YF. Intrahepatic distribution of hepatitis B surface and core antigens in chronic hepatitis B virus infection. Hepatocyte with cytoplasmic/membranous hepatitis B core antigen as a possible target for immune hepatocytolysis. Gastroenterology 1987;92:220.
42. Chu CM, Yeh CT, Sheen IS, Liaw YF. Subcellular localization of Hepatitis B core antigen in relation to hepatocyte regeneration in chronic hepatitis B. Gastroenterology 1995;109:1926-32.
43. Villari D, Pollicino T, Spinella S, Russo F, Campo S, Rodino G, et al. Hepatitis Be antigen detection in formalin fixed liver biopsy specimens. A tool to investigate wild-type and e-minus variant HBV infection. Am J Clin Patrol 1995;103:136-40.
44. Yamada G, Takaguchi K, Matsueda K, Nishimoto H, Takahashi M, Fujiki S, et al. Immunoelectron microscopic observation of intrahepatic HBeAg in patients with chronic hepatitis B. Hepatology 1990;12:133-40.
45. Hadziyannis SJ, Lieberman HM, Karvountzis GG, Shafritz DA. Analysis of liver disease, nuclear HBcAg, viral replication, and hepatitis B virus DNA in liver and serum of HBeAg vs anti-HBe positive carriers of hepatitis B virus. Hepatology 1983;3:656-62.
46. Su IJ, Lai MY, Hsu HC, Chen DS, Yang PM, Chuang SM, et al. Diverse virological, histopathological and prognostic implications of seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection. J Hepatol 1986;3:182-9.
47. Davis GL, Hoofnagle JH. Reactivation of chronic type B hepatitis presenting as acute viral hepatitis. Ann Int Med 1985;102:762-5.
48. Shafritz DA, Hadziyannis SJ. Molecular pathobiology of persistent hepatitis B virus infection in relation to chronic liver disease and primary hepatocellular carcinoma. In: Farber E, Phillips MJ, Kaufman N, editors. Pathogenesis of liver diseases. Baltimore: Williams and Wilkins; 1987. p. 136-52.
49. Martinot-Peignoux M, Boyer N, Colombat M, Akremi R, Pham BN, Ollivier S, et al. Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers. J Hepatol 2002;36:543-6.
50. Perillo RP, Brunt EM. Hepatic histologic and immunohistochemical changes in chronic hepatitis B after prolonged clearance of HBeAg and hepatitis B surface antigen. Ann Int Med 1991;115:113-5.
51. Naoumov NV, Schneider R, Grötzinger T, et al. Precore mutant hepatitis B virus infection and liver disease. Gastroenterology 1992;102:538-43.
52. Naoumov NV, Eddleston ALWF. Host immune response and variations in the virus genome: pathogenesis of liver damage caused by hepatitis B virus. Gut 1994;35:1013-7.
53. Park YN, Han KH, Kim KS, Chung JP, Kim S, Park C. Cytoplasmic expression of hepatitis B core antigen in chronic hepatitis B virus infection: role of precore stop mutants. Liver 1999;19:199-205.
54. Bonino F, Rosina F, Rizzetto M, Rizzi R, Chiaberge E, Tardanico R, et al. Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe. Gastroenterology 1986;90:1268-73.
55. Dienes HP, Gerken G, Goergen B, Heermann K, Gerlich W, Meyer zum Büschenfelde KH. Analysis of the precore DNA sequence and detection of precore antigen in liver specimens from patients with anti-hepatitis-B-e positive chronic hepatitis. Hepatology 1995;21:1-7.
56. Wang WL, London WT, Lega L, Feitelson MA. HB x Ag in the liver from carrier patients with chronic hepatitis and cirrhosis. Hepatology 1991;14:29-37.
57. Wang WL, London WT, Feitelson MA. Hepatitits B x antigen in hepatitis B virus carrier patients with liver cancer. Cancer Res 1991;51:4971-7.
58. Negro F, Pacchioni D, Monardini A, Bussolati G, Bonino F. In situ hybridization in viral hepatitis. Liver 1992;12:217-26. (Spec. issue).
59. Naoumov NV, Daniels HM, Davison F, Eddleston ALWF, Alexander GJM, Williams R. Identification of hepatitis B virus-DNA in the liver by in situ hybridization using a biotinylated probe. Relation to HBcAg expression and histology. J Hepatol 1993;19:204-10.
60. Lau JYN, Naoumov NV, Alexander GJM, Williams R. Rapid detection of hepatitis B virus DNA in liver tissue by in situ hybridization and its combination with immunohistochemistry for simultaneous detection of HBV antigens. J Clin Pathol 1991;44:905-8.
61. Bianchi L, Gudat F. Chronic hepatitis. In: MacSween RNM, Anthony PP, Scheuer PJ, Portmann B, Burt AD, editors. Pathology of the liver, 3rd ed. Edinburgh: Churchill Livingstone; 1994, p. 349-95.
62. De Groote J, Desmet VJ, Gedigk P, Korb G, Popper H, Poulsen H, et al. A classification of chronic hepatitis. Lancet 1968;II:626-8.
63. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994;19:1513-20.
64. International Working Party, Terminology of chronic hepatitis, hepatic allograft rejection, and nodular lesions of the liver: summary of recommendations developed by an international working party, supported by the World Congresses of Gastroenterology, Los Angeles, 1994. Am J Gastroenterol 1994;89:S177-81.
65. Hübscher SG. Histological grading and staging in chronic hepatitis: clinical applications and problems. J Hepatol 1998;29:1015-22.
66. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-5.
67. French METAVIR Cooperative Study Group, Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994;20:15-20.
68. Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 1991;13:372-4.
69. Batts KP, Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 1995;19:1409-17.
70. Bedossa P, Poynard T, METAVIR Cooperative Study Group. An algorithm for the grading of activity in chronic hepatitis C. Hepatology 1996;24:289-293
71. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997;349:825-32.
72. Goldin RD, Goldin JG, Burt AD, Dhillon PA, Hubscher S, Wyatt J. Intra-observer and inter-observer variation in the histopathological assessment of chronic viral hepatitis. J Hepatol 1996;25:649-54.
73. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696-9.
74. Westin J, Lagging LM, Westjal R, Norkrans G, Dhillon P. Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection. Liver 1999;19:183-7.
75. Scheuer PJ, Standish RA, Dhillon AP. Scoring of chronic hepatitis. Clin Liver Dis 2002;6:335-47.
76. Dusheiko GM. New treatments for chronic viral hepatitis B and C. Baillière's Clin Gastroenterol 1996;10:299-333.
77. Chevallier M, Guerret S, Chossegros P, Gerard F, Grimaud JA. A histological semiquantitative scoring system for evaluation of hepatic fibrosis in needle liver biopsy specimens: comparison with morphometric studies. Hepatology 1994;20:349-55.
78. Pilette C, Rousselet MC, Bedossa P, Chappard D, Oberti F, Rifflet H, et al. Histopathological evaluation of liver fibrosis: quantitative image analysis versus semi-quantitative scores. Comparison with serum markers. J Hepatol 1998;28:439-46.
79. Masseroli M, Caballero T, O'Valle F, Del Moral RMG, Perez-Milena A, Del Moral RG. Automatic quantification of liver fibrosis: design and validation of a new image analysis method: comparison with semiquantitative indexes of fibrosis. J Hepatol 2000;32:453-64.
80. Dioguardi N, Grizzi F, Bossi P, Roncalli M. Fractal and spectral dimension analysis of liver fibrosis in needle biopsy specimens. Anal Quant Cytol Histol 1999;21:262-6.
81. Moal F, Chappard D, Wang J, Vuillemin E, Michalak-Provost S, Rousselet MC, et al. Fractal dimension can distinguish models and pharmacologic changes in liver fibrosis in rats. Hepatology 2002;36:840-9.
82. Okuda K. Hepatocellular carcinoma. J Hepatol 2000;32(Suppl. I):225-37.
83. Chisari FV. Viruses, immunity and cancer: lessons from hepatitis B. Am J Pathol 2000;156:1118-32.
84. Anthony PP, Vogel CL, Barker LF. Liver cell dysplasia: a premalignant condition. J Clin Pathol 1973;26:217-23.
85. Watanabe S, Okita K, Harada T, Kodama T, Numa Y, Takemoto T, et al. Morphologic studies of the liver cell dysplasia. Cancer 1983;51:2197-205.
86. Libbrecht L, Craninx M, Nevens F, Desmet V, Roskams T. Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with non-cirrhotic and cirrhotic chronic viral hepatitis. Histopathology 2001;39:66-73.
87. Libbrecht L, Desmet V, Van Damme B, Roskams T. The immunohistochemical phenotype of dysplastic foci in human liver: correlation with putative progenitor cells. J Hepatol 2000;33:76-84.
88. International Working Party, Terminology of nodular hepatocellular lesions. Hepatology 1995;22:983-93.
89. Kojiro M. Premalignant lesions of hepatocellular carcinoma: pathologic viewpoint. J Hepatobiliary Pancreatic Surg 2000;7:535-41.
90. Le Bail B, Bernard PH, Carles J, Balabaud C, Bioulac-Sage P. Prevalence of liver cell dysplasia and association with HCC in a series of 100 cirrhotic liver explants. J Hepatol 1997;27:835-42.
91. Verme G, Amoroso P, Lettieri G, Pierri P, David E, Sessa F, et al. A histologic study of hepatitis delta virus liver disease. Hepatology 1986;6:1303-7.
92. Buitrago B, Popper H, Hadler SC, Thung SN, Gerber MA, Purcell RH. Specific histologic features of Santa Marta hepatitis. A severe form of hepatitis delta-virus infection in northern South America. Hepatology 1986;6:1285-91.
93. Lefkowitch JH, Goldstein H, Yatto R, Gerber MA. Cytopathic liver injury in acute delta virus hepatitis. Gastroenterology 1987;92:1262-6.
94. Di Bisceglie AM, Negro F. Diagnosis of hepatitis delta virus infection. Hepatology 1989;10:1014-6.
95. Kojima T, Callea F, Desmyter J, Sakurai I, Desmet VJ. Immunolight and electron microscopic features of chronic hepatitis D. Liver 1990;10:17-27.
96. Ryley NG, Heryet AR, Goldin R, Monjardino J, Saldanha J, Fleming KA. Co-expression of markers for hepatitis delta and hepatitis B viruses in human liver. Histopathology 1992;20:331-7.
97. Negro F, Bonino F, Di Bisceglie A, Hoofnagle JH, Gerin JL. Intrahepatic markers of hepatitis delta virus infection. A study by in situ hybridization. Hepatology 1989;10:916-20.
98. Pacchioni D, Negro F, Chiaberge E, Rizzetto M, Bonino F, Bussolati G. Detection of hepatitis Delta virus RNA by a nonradioactive in situ hybridization procedure. Hum Pathol 1992;23:557-61.
99. Davies SE, Portmann BC, O'Grady JG, Aldis PM, Chaggar K, Alexander GJM, et al. Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis. Hepatology 1991;13:150-7.
100. Harrison RF, Davies MH, Goldin RD, Hübscher SG. Recurrent hepatitis B in allografts: a distinctive form of rapidly developing cirrhosis. Histopathology 1993;23:21-8.
101. Phillips MJ, Cameron R, Flowers MA, Blendis LM, Greig PD, Wanless I. Post transplant recurrent hepatitis B viral liver disease. Am J Pathol 1992;140:1295-308.
102. Hübscher SG, Portmann BC. Transplantation pathology. In: MacSween RNM, Burt AD, Portmann BC, Ishak KG, Scheuer PJ, Anthony PP, editors. Pathology of the liver. London: Churchill Livingstone; 2002. p. 228-941.
103. Fang J, Wright T, Lau J. Fibrosing cholestatic hepatitis in a patient with HIV and hepatitis B. Lancet 1993;342:1175.
104. Booth JCL, Goldin RD, Brown JL, Karayiannis P, Thomas HC. Fibrosing cholestatic hepatitis in a renal transplant recipient associated with the hepatitis B virus precore mutant. J Hepatol 1995;22:500-3.
105. Colombari R, Dhillon AP, Piazzola E, Tomezzoli AA, Angelini GP, Capra F, et al. Chronic hepatitis in multiple virus infection: histopathological evaluation. Histopathology 1993;22:319-25.
106. Guido M, Thung SN, Fattovich G, Cusinato R, Leandro G, Cecchetto A, et al. Intrahepatic expression of hepatitis B virus antigens: effect of hepatitis C virus infection. Mod Pathol 1999;12:599-603.
107. Goodman ZD, Ishak KG. Histopathology of hepatitis C virus infection. Semin Liver Dis 1995;15:70-81.
108. Verslype C, Nevens F, Sinelli N, Clarysse C, Pirenne J, Depla E, et al. Hepatic immunohistochemical staining with a monoclonal antibody against HCV-E2 to evaluate antiviral therapy and reinfection of liver grafts in hepatitis C viral infection. J Hepatol 2003;38:208-14.
109. Goldin RD, Fish DE, Hay A, Waters JA, McGarvey MJ, Main J. Histological and immunohistochemical study of hepatitis B virus in human immunodeficiency virus infection. J Clin Pathol 1990;43:203-5.
110. Housset C, Pol S, Carnot F, Dubois F, Nalpas B, Housset B, et al. Interactions between human immunodeficiency virus-1, hepatitis delta virus and hepatitis B virus infections in 260 chronic carriers of hepatitis B virus. Hepatology 1992;15:578-83.
111. Kweon YO, Goodman ZD, Dienstag JL, Schiff ER, Brown RA, Burkhardt E, et al. Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B. J Hepatol 2001;35:749-55.
112. Huang SN, C CT, Tsai SL, Liaw YF. Histopathology and pathobiology of hepatotropic virus-induced liver injury. J Gastroenterol Hepatol 1997;12(Suppl.):S195-S217.
113. Moreno-Otero R, Gracia-Buey L, Mateos F, Garcia-Monzon C. Pathogenesis of chronic viral hepatitis: lessons from immunohistochemistry. Viral Hepat Rev 1996;2:61-79.
114. Maher JH. Cytokines: overview. Semin Liver Dis 1999;19:109-15.
115. Koziel MJ. Cytokines in viral hepatitis. Semin Liver Dis 1999;19:157-69.
116. Kojima N, Horiike N, Michitaka K, Onji M. In situ detection of mutated hepatitis B virus in microdissected, formalin-fixed liver tissue from patients with chronic hepatitis B. J Hepatol 1999;30:359-65.
117. Honda M, Kaneko S, Kawai H, Shirota Y, Kobayashi K. Differential gene expression between chronic hepatitis B and C hepatic lesion. Gastroenterology 2001;120:955-66.
118. Gillespie JW, Best CJ, Bichsel VE, Cole KA, Greenhut SF, Hewitt SM, et al. Technical advance. Evaluation of non-formalin tissue fixation for molecular profiling studies. Am J Pathol 2002;160:449-57.